Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial

Clinical Trials

Volumn 6, Issue 6, 2009, Pages 618-627

  Bell, Margaret C ^a   Robuck, Patricia R ^b   Wright, Elizabeth C ^b   Mihova, Marina S ^a   Hofmann, Charlotte ^c   De Santo, Jennifer L ^d   Milstein, Susan L ^e   Richtmyer, Pamela A ^a,f   Shelton, Janel L ^g   Cormier, Maureen ^h,i   King, Debra L ^j   Park, Choon J ^k   Molchen, Wallis A ^l   Park, Yoon ^b   Kelley, Michelle ^m,n  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF MASSACHUSETTS   (United States)

ⁱ VERTEX PHARMACEUTICALS   (United States)

^j SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

ⁿ University of Massachusetts   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; HEPATITIS C; HUMAN; INFORMATION PROCESSING; LIVER FIBROSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIVIRAL AGENTS; AUTOMATIC DATA PROCESSING; CARCINOMA, HEPATOCELLULAR; DATABASE MANAGEMENT SYSTEMS; DISEASE PROGRESSION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; MULTICENTER STUDIES AS TOPIC; NATIONAL INSTITUTES OF HEALTH (U.S.); POLYETHYLENE GLYCOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; UNITED STATES;

EID: 77149127369     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774509348525     Document Type: Article

References (15)

1. Mitchell R, Shah M, Ahmad S et al. A unified web-based query and notification system (QNS) for subject management, adverse events, regulatory, and IRB components of clinical trials. Clin Trials 2005;2:61-71.
2. Silverman DI, Cirullo L, DeMartinis NA et al. Systematic identification and classification of adverse events in human research. Contemp Clin Trials 2006;27:295-303.
3. *D) project. Clin Trials 2004;1:387-98.
4. Lee WM, Dienstag JL, Lindsay KL et al. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials 2004;25:472-92.
5. U. S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), April 1996. International Conference on Harmonization (ICH) Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance; Available at: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm073122.pdf (accessed 11 September 2009).
6. FDA. 21 CFR Part 312.32 Investigational New Drug Application (IND-IND Safety Reports; Available at: http://www.research.buffalo.edu/rsp/ 21CFR312.cfm# 312.32-IND-safety-reports (accessed 11 September 2009)).
7. Clinical Data Management. New England Research Institutes, Inc. Available at: http://www.neriscience.com/web/MultiPiecePage.asp-Q-PageID-E-13-A- Page Name-E-Datamanagement (accessed 19 February 2009).
8. Online ICD-9 Codes. Available at: http://icd9cm.chrisendres.com/ icd9cm/(accessed 19 February 2009).
9. Jinjuvadia K, Kwan W, Fontana RJ. Searching for a needle in a haystack: use of ICD-9-CM codes in druginduced liver injury. Am J Gastroenterol 2007;102:2437-43.
10. Reuben A. Needles in haystacks. Am J Gastroenterol 2007;102:2444-46.
11. Health Insurance Portability and Accountability Act. Health Information Privacy. U. S. Department of Health and Human Services; Available at: http://www.hhs.gov/ocr/privacy/hipaa/understanding/index.html (accessed 11 September 2009).
12. ®. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Available at: http://www.meddramsso.com/MSSOWeb/index.htm (accessed 11 September 2009).
13. SNOMED CT. International Health Terminology Standards Development Organisation (IHTSDO). Available at: http://www.ihtsdo.org/(accessed 11 September 2009).
14. Richesson RL, Fung KW, Krischer JP. Heterogeneous but 'standard' coding systems for adverse events: Issues in achieving interoperability between apples and oranges. Contemp Clin Trials 2008;29:635-45.
15. Trotti A, Colevas AD, Setser A, Basch E. Patientreported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 2007;25:5121-27.